Abstract
Objectives
The aim of this study was to evaluate the levels of salivary and serum interleukin (IL)-1β, visfatin, and omentin-1 in the relationship between periodontal disease and overweight/obesity as well as to reveal the possible role of periodontal inflamed surface area (PISA) in this association.
Materials and methods
Ninety-six individuals (69 females, 27 males) were divided into 4 groups as systemically healthy (H) and non-periodontitis (HnP, n = 23), systemically healthy and periodontitis (HP, n = 24), overweight/obese (O) and non-periodontitis (OnP, n = 25), and overweight/obese and periodontitis (OP, n = 24). Periodontal parameters were measured, and PISA was calculated. IL-1β, visfatin, and omentin-1 levels in saliva and serum samples were analysed.
Results
Periodontal parameters deteriorated, salivary and serum IL-1β and visfatin levels were increased, and omentin-1 levels were decreased in OnP and OP groups, compared to HnP and HP groups. Salivary and serum IL-1β and visfatin levels were increased and omentin-1 levels were decreased in periodontitis groups, compared to HnP and OnP groups. PISA was negatively correlated with salivary omentin-1 and positively correlated with salivary and serum visfatin in H and O groups, whereas a positive relationship was found between PISA and salivary and serum IL-1β in H group.
Conclusions
PISA may be negatively associated with salivary omentin-1, while positively correlated with salivary and serum visfatin in overweight/obese patients.
Clinical relevance.
Co-evaluation of PISA and adipokines seems to be an innovative approach to evaluate the association between periodontitis and overweight/obesity.
Similar content being viewed by others
References
Al-Zahrani MS, Bissada NF, Borawskit EA (2003) Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 74(5):610–615. https://doi.org/10.1902/jop.2003.74.5.610
PJ Pussinen E Kopra M Pietiainen M Lehto S Zaric S Paju A Salminen 2022 Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia Periodontol 2000https://doi.org/10.1111/prd.12433
Pirih FQ, Monajemzadeh S, Singh N, Sinacola RS, Shin JM, Chen T, Fenno JC, Kamarajan P, Rickard AH, Travan S, Paster BJ (2000) Kapila Y (2021) Association between metabolic syndrome and periodontitis: the role of lipids, inflammatory cytokines, altered host response, and the microbiome. Periodontol 87(1):50–75. https://doi.org/10.1111/prd.12379
Darveau RP (2000) Curtis MA (2021) Oral biofilms revisited: a novel host tissue of bacteriological origin. Periodontol 86(1):8–13. https://doi.org/10.1111/prd.12374
Hajishengallis G (2000) Lamont RJ (2021) Polymicrobial communities in periodontal disease: their quasi-organismal nature and dialogue with the host. Periodontol 86(1):210–230. https://doi.org/10.1111/prd.12371
Teles F, Wang Y, Hajishengallis G, Hasturk H (2000) Marchesan JT (2021) Impact of systemic factors in shaping the periodontal microbiome. Periodontol 85(1):126–160. https://doi.org/10.1111/prd.12356
Joseph S (2000) Curtis MA (2021) Microbial transitions from health to disease. Periodontol 86(1):201–209. https://doi.org/10.1111/prd.12377
Nesse W, Abbas F, van der Ploeg I, Spijkervet FK, Dijkstra PU, Vissink A (2008) Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 35(8):668–673. https://doi.org/10.1111/j.1600-051X.2008.01249.x
Ana P, Dimitrije M, Ivan M, Mariola S (2016) The association between periodontal disease and obesity among middle-aged adults periodontitis and obesity. J Metabolic Synd 5(208). https://doi.org/10.4172/2167-0943.1000208
Aoyama N, Fujii T, Kida S, Nozawa I, Taniguchi K, Fujiwara M, Iwane T, Tamaki K, Minabe M (2021) Association of periodontal status, number of teeth, and obesity: a cross-sectional study in japan. J Clin Med 10(2). https://doi.org/10.3390/jcm10020208
Vijayalakshmi R, Thamaraiselvan JM, Srinivasan S, Kumari BN (2020) Obesity and periodontal disease–an overview. IP Int J Periodontol Implantol 5(1):1–5
Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M, Bluher M (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54(10):2911–2916. https://doi.org/10.2337/diabetes.54.10.2911
Dedoussis GV, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M, Siest G, Visvikis-Siest S (2009) Visfatin: the link between inflammation and childhood obesity. Diabetes Care 32(6):e71. https://doi.org/10.2337/dc08-2304
Ozcan E, Saygun NI, Ilikci R, Karslioglu Y, Musabak U, Yesillik S (2017) Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation. Clin Oral Investig 21(4):1113–1121. https://doi.org/10.1007/s00784-016-1871-7
Pradeep AR, Raghavendra NM, Prasad MV, Kathariya R, Patel SP, Sharma A (2011) Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. J Periodontol 82(9):1314–1319. https://doi.org/10.1902/jop.2011.100690
Tabari ZA, Azadmehr A, Nohekhan A, Naddafpour N, Ghaedi FB (2014) Salivary visfatin concentrations in patients with chronic periodontitis. J Periodontol 85(8):1081–1085. https://doi.org/10.1902/jop.2013.130388
Turer CC, Balli U, Guven B, Cetinkaya BO, Keles GC (2016) Visfatin levels in gingival crevicular fluid and serum before and after non-surgical treatment for periodontal diseases. J Oral Sci 58(4):491–499. https://doi.org/10.2334/josnusd.16-0116
Li Z, Lu C, Qiu J, Liu S, Liu X, Ma S, Lai R (2018) Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease. Int J Clin Exp Pathol 11(3):1620–1628
Kumar V, Pratap M, Sharma S, Singh K, Saimbi CS (2019) Evaluation of salivary levels of visfatin in obese patients with chronic periodontitis. Indian J Dent Sci 11:20–24. https://doi.org/10.4103/IJDS.IJDS_92_18
Cetiner D, Uraz A, Oztoprak S, Akca G (2019) The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease. J Appl Oral Sci 27:e20180365. https://doi.org/10.1590/1678-7757-2018-0365
Rao SS, Hu Y, Xie PL, Cao J, Wang ZX, Liu JH, Yin H, Huang J, Tan YJ, Luo J, Luo MJ, Tang SY, Chen TH, Yuan LQ, Liao EY, Xu R, Liu ZZ, Chen CY, Xie H (2018) Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines. Bone Res 6:9. https://doi.org/10.1038/s41413-018-0012-0
Pan HY, Guo L, Li Q (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88(1):29–33. https://doi.org/10.1016/j.diabres.2010.01.013
Zhao A, Xiao H, Zhu Y, Liu S, Zhang S, Yang Z, Du L, Li X, Niu X, Wang C, Yang Y, Tian Y (2022) Omentin-1: a newly discovered warrior against metabolic related diseases. Expert Opin Ther Targets:1–15. https://doi.org/10.1080/14728222.2022.2037556
de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56(6):1655–1661. https://doi.org/10.2337/db06-1506
Balli U, Bozkurt Dogan S, Ongoz Dede F, Sertoglu E, Keles GC (2016) The levels of visceral adipose tissue-derived serpin, omentin-1 and tumor necrosis factor-alpha in the gingival crevicular fluid of obese patients following periodontal therapy. J Oral Sci 58(4):465–473. https://doi.org/10.2334/josnusd.16-0212
WHO (2000) Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. In. World Health Organization, Geneva
Silness J, Löe H (1964) Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22(1):121–135.
Löe H, Silness J (1963) Periodontal disease in pregnancy I. Prevalence and severity Acta Odontol Scand 21(6):533–551
Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H (2018) Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol 89(Suppl 1):S74–S84. https://doi.org/10.1002/JPER.17-0719
Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Clin Periodontol 45(Suppl 20):S149–S161. https://doi.org/10.1111/jcpe.12945
Navazesh M (1993) Methods for collecting saliva. Ann N Y Acad Sci 694(1):72–77
Brum RS, Duarte PM, Canto GL, Flores-Mir C, Benfatti CAM, Porporatti AL, Zimmermann GS (2020) Biomarkers in biological fluids in adults with periodontitis and/or obesity: A meta-analysis. J Indian Soc Periodontol 24(3):191–215. https://doi.org/10.4103/jisp.jisp_512_19
Dalla Vecchia CF, Susin C, Rosing CK, Oppermann RV, Albandar JM (2005) Overweight and obesity as risk indicators for periodontitis in adults. J Periodontol 76(10):1721–1728. https://doi.org/10.1902/jop.2005.76.10.1721
Nishida N, Tanaka M, Hayashi N, Nagata H, Takeshita T, Nakayama K, Morimoto K, Shizukuishi S (2005) Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. J Periodontol 76(6):923–928. https://doi.org/10.1902/jop.2005.76.6.923
Wood N, Johnson RB, Streckfus CF (2003) Comparison of body composition and periodontal disease using nutritional assessment techniques: Third National Health and Nutrition Examination Survey (NHANES III). J Clin Periodontol 30(4):321–327. https://doi.org/10.1034/j.1600-051x.2003.00353.x
Takeda K, Mizutani K, Minami I, Kido D, Mikami R, Konuma K, Saito N, Kominato H, Takemura S, Nakagawa K, Izumi Y, Ogawa Y, Iwata T (2021) Association of periodontal pocket area with type 2 diabetes and obesity: a cross-sectional study. BMJ Open Diabetes Res Care 9(1). https://doi.org/10.1136/bmjdrc-2021-002139
Cheng R, Wu Z, Li M, Shao M, Hu T (2020) Interleukin-1beta is a potential therapeutic target for periodontitis: a narrative review. Int J Oral Sci 12(1):2. https://doi.org/10.1038/s41368-019-0068-8
Abulnaja KO (2009) Changes in the hormone and lipid profile of obese adolescent Saudi females with acne vulgaris. Braz J Med Biol Res 42(6):501–505. https://doi.org/10.1590/s0100-879x2009000600005
Sonoli SS, Shivprasad S, Prasad CV, Patil AB, Desai PB, Somannavar MS (2011) Visfatin–a review. Eur Rev Med Pharmacol Sci 15(1):9–14
Funding
Hatay Mustafa Kemal University Scientific Research Projects Commission (Project number: 18.M.094) financially supported the current study.
Author information
Authors and Affiliations
Contributions
Conceptualization: Esra Sinem Kemer Doğan.
Formal Analysis: Esra Sinem Kemer Doğan; Nizami Duran.
Investigation: Esra Sinem Kemer Doğan.
Methodology: Esra Sinem Kemer Doğan; Nizami Duran.
Writing — original draft: Esra Sinem Kemer Doğan.
Writing — review and editing: Esra Sinem Kemer Doğan; Nizami Duran.
Corresponding author
Ethics declarations
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the Hatay Mustafa Kemal University, Tayfur Ata Sökmen Medical Faculty, Clinical Research Ethics Committee (No. 2018/149).
Consent to participate
Written informed consent form was obtained from the patients.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kemer Doğan, E.S., Duran, N. Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?. Clin Oral Invest 26, 5351–5358 (2022). https://doi.org/10.1007/s00784-022-04502-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-022-04502-0